Join

Compare · BDX vs NVAC

BDX vs NVAC

Side-by-side comparison of Becton Dickinson and Company (BDX) and NorthView Acquisition Corporation (NVAC): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both BDX and NVAC operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • BDX is the larger of the two at $43.32B, about 183.8x NVAC ($235.6M).
  • Over the past year, BDX is down 25.7% and NVAC is up 0.0% - NVAC leads by 25.7 points.
  • BDX has hit the wire 9 times in the past 4 weeks while NVAC has been quiet.
  • BDX has more recent analyst coverage (25 ratings vs 0 for NVAC).
PerformanceBDX-1.57%NVAC+0.00%
2026-04-02+0.00%2026-04-24
MetricBDXNVAC
Company
Becton Dickinson and Company
NorthView Acquisition Corporation
Price
$152.11-1.77%
$11.37+0.98%
Market cap
$43.32B
$235.6M
1M return
-3.89%
+0.00%
1Y return
-25.68%
+0.00%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NYSE
NASDAQ
IPO
2022
News (4w)
9
0
Recent ratings
25
0
BDX

Becton Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps, dedicated disposables, IV fluids, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.

NVAC

NorthView Acquisition Corporation

NorthView Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare sector. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation is a subsidiary of NorthView Sponsor I, LLC.

Latest BDX

Latest NVAC